Glenmede Trust CO Na Phibro Animal Health Corp Transaction History

Glenmede Trust CO Na

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$16.44 - $20.2 $3,600 - $4,423	-219 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$17.36 - $26.36 $711 - $1,080	-41 Reduced 15.77%	219 $3,000
Q2 2020 Aug 14, 2020	SELL	$22.31 - $28.29 $1,628 - $2,065	-73 Reduced 21.92%	260 $6,000
Q4 2019 Feb 12, 2020	BUY	$21.0 - $24.83 $2,499 - $2,954	119 Added 55.61%	333 $8,000
Q2 2019 Aug 13, 2019	BUY	$28.03 - $36.85 $1,149 - $1,510	41 Added 23.7%	214 $6,000
Q4 2018 Feb 14, 2019	BUY	$31.18 - $44.64 $5,394 - $7,722	173 New	173 $5,000

148

20.4M

Ticker PAHC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 20,337,600
Market Cap $440M
Description
Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for poultry, swine, beef and dairy c...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.